CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’

CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’

Source: 
BioPharma Dive
snippet: 

23andMe has cemented its place as a go-to provider of at-home genetic testing over the past two decades. Along the way, the company has also been working toward its long-term vision of becoming a full-fledged biotech.